BNP Paribas Financial Markets’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-76
| Closed | -$9.41K | – | 3618 |
|
|
2020
Q2 | $9.41K | Sell |
76
-147
| -66% | -$18.2K | ﹤0.01% | 3112 |
|
|
2020
Q1 | $43K | Buy |
223
+171
| +329% | +$33K | ﹤0.01% | 3007 |
|
|
2019
Q4 | $17.4K | Buy |
52
+25
| +93% | +$8.36K | ﹤0.01% | 3366 |
|
|
2019
Q3 | $8.61K | Buy |
27
+1
| +4% | +$319 | ﹤0.01% | 3538 |
|
|
2019
Q2 | $11.4K | Sell |
26
-3
| -10% | -$1.32K | ﹤0.01% | 3450 |
|
|
2019
Q1 | $16.5K | Buy |
29
+24
| +480% | +$13.7K | ﹤0.01% | 3355 |
|
|
2018
Q4 | $1.57K | Buy |
5
+2
| +67% | +$626 | ﹤0.01% | 3164 |
|
|
2018
Q3 | $1.99K | Hold |
3
| – | – | ﹤0.01% | 3586 |
|
|
2018
Q2 | $1.91K | Sell |
3
-13
| -81% | -$8.27K | ﹤0.01% | 3606 |
|
|
2018
Q1 | $43.3K | Buy |
+16
| New | +$43.3K | ﹤0.01% | 3049 |
|